---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-020815"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:29:22.235891+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical launches limited U.S. commercial release of LIBERTY robotic system

## Summary
- LIBERTY Endovascular Robotic System now commercially available in U.S. on a limited basis after FDA 510(k) clearance in September 2025.
- Limited Market Release (LMR) targets high procedure volume regions with existing preliminary demand; Full Market Release (FMR) planned for April 2026 at Society of Interventional Radiology meeting.
- Company has hired core commercial team and secured third-party logistics partner to support the launch.
- CEO Harel Gadot states the launch marks entry into commercialization phase, building a new robotic category with single-use system.

## SEC filing metadata
- accession: 0001493152-25-020815
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315225020815/0001493152-25-020815-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315225020815/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-020815
- JSON: https://secwatch.observer/filing/0001493152-25-020815.json
- Plain text: https://secwatch.observer/filing/0001493152-25-020815.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.